COVID-19 vaccine supply chain management: a US perspective

Vaccine Insights 2022; 1(1), 71–77

DOI: 10.18609/vac.2022.012

Published: 7 June 2022
Commentary
Michael Angelastro, Robert A Johnson

The COVID-19 pandemic has had a dramatic impact on vaccine industry supply chains. Reliance on just-in-time supply chains and limited capacity posed challenges for vaccine manufacturers as they rapidly and dramatically scaled-up production. Supply chain management and expansion are as important as vaccine development itself, and here we outline how the US Government has worked with multiple stakeholders to support supply chains and maximize ‘shots in arms’ – and what is needed to ensure we are better prepared for future outbreaks.